LIFE SCIENCES & HEALTHCARE

Because innovation is everything

Home
Capabilities
Life Sciences and Healthcare

With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.

Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 270 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.

We can advise you on:

Technology transfers and IP Licensing
R&D collaborations
Patent and trade mark disputes and IP strategy
Clinical trials
Privacy and data protection
Regulatory and data exclusivity
Corporate transactions (including fundraising, IPOs and M&A)
Competition law
e-health, m-health and digitalisation
Marketing arrangements and advertising
Pricing and reimbursement
Public procurement
Product liability
Employment

If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.

Show More Show Less

Related capabilities

Digital Health Healthcare Life Sciences Medical Devices

BioTalk

By the Life Sciences & Healthcare Group at Bird & Bird

Meet the Life Sciences and Healthcare team

See the full team

Mark Hilton

Partner
UK

Marc Martens

Partner
Belgium

Sally Shorthose

Partner
UK

See the full team

Discover the world of telemedicine

An international overview of the regulatory legislation

Download pdf

M-health & Medical Apps

The Key Legal Issues

Navigating the Legal Aspects of Mobile Health

Life Sciences & Healthcare

pdf

Nov 18 2022

Download

The Legal 500: Pharmaceutical Advertising Comparative Guide 2022 - UK Chapter

pdf

Jan 23 2023

Download

The Legal 500: Pharmaceutical Advertising Comparative Guide 2022 - UK Chapter

pdf

Jan 23 2023

Download

Show More Show Less

Australian regulators are shining a spotlight on #greenwashing and taking enforcement action against businesses promoting dubious #ESG claims. Click here to read more: https://t.co/fHitfE81hR https://t.co/2SPhonWnEW

twobirds | Mar 30

We are delighted to announce that Graeme Maguire has been reappointed as Chair, effective 1 April 2023. A huge congratulations to Graeme. Click here to read more: https://t.co/OgV03lmVSz https://t.co/yCoAy5PSWS

twobirds | Mar 29

In this recent article, we discuss the potential regulatory implications for crypto-asset service providers who intend to offer services related to these assets. Click here to read more: https://t.co/vAKSpy52Uw https://t.co/M965xgKL3S

twobirds | Mar 28

We are delighted to share the latest edition of Check-in - our quarterly newsletter helping you stay up to date with the latest news, trends and hot topics in the international Hotels, Hospitality & Leisure market. Click here to read more: https://t.co/BufyepeIYf https://t.co/hhuUNJVAji

twobirds | Mar 27

Despite the Hotel sector having a successful year, there are concerns that many hotels have not been receiving sufficient investment. Find out how the private equity sector views the opportunities within the hotel sector at present in our upcoming webinar: https://t.co/LjBffm3Dvt https://t.co/DC2nLsll8k

twobirds | Mar 23

Join The Conversation

Accolades

Chambers and Partners 2021 – Life Sciences: Europe-wide - Band 1 Asia-Pacific- Band 1 UK Life Sciences & Pharmaceutical Sector (International & Cross-Border) - Band 1

Chambers and Partners 2021 – Life Sciences

"They take a pragmatic and commercial approach, and are able to explain complex concepts in a simple and easy to understand format."

Chambers and Partners, Asia-Pacific 2021

"We chose Bird & Bird because they are internationally oriented. They come up with decisions that are favourable for the client and do not just prolong litigation."

Chambers and Partners, Global 2021

“[The team] provides geographical breadth and uniform excellence throughout. They are excellent and know the nuts and bolts of life sciences."

Chambers and Partners, UK 2022

Chambers & Partners UK 2022 – Life Sciences: Band 1

Chambers & Partners UK 2022

“Working with Bird & Bird was a pleasure. It was a real team effort and they worked well together to get the best result.”

Chambers Europe 2021

"They remain at the pinnacle of the profession as regards their life sciences work."

Legal 500, 2020

“This practice is unique because they have such great experience and knowledge in such a large amount of localities. They are great to work with because they have very talented attorneys in lots of countries and can really help out international companies and support their growth.”

Legal 500 2022

Legal 500 UK 2022 – Life Sciences and Healthcare: Tier 1

Legal 500 UK 2022

LMG Life Sciences Europe Awards 2021: European Regulatory Firm of the Year, European Venture Capital Firm of the Year, Patent Litigation Firm of the Year – Medical Devices

LMG Life Sciences Europe Awards 2021

LMG Life Sciences Awards EMEA 2022

LMG Life Sciences Awards EMEA 2022
Two Impact Case of the Year Awards
- CE - 450163 Doctolib successful before Conseil d'État
- Pharmaceutical Works Polpharma SA v European Medicines Agency (EMA).

Who's Who Legal 2020

Global Firm of the Year -
Life Sciences Patent Litigation

Bird & Bird

Managing Intellectual Property
Impact Case of the Year
Shenzen Senior Technology
Material Co v Celgard
Managing Intellectual Property EMEA Awards 2021

Click here

LIFE SCIENCES & HEALTHCARE

Because innovation is everything

Our International Life Sciences & Healthcare group works with over 50% of the world’s largest pharmaceutical, biotechnology and medical devices companies. We have the largest patent litigation group in Europe and are recognised by major global directories as a top tier life sciences firm.

Related capabilities

Related Content

BioTalk

Meet the Life Sciences and Healthcare team

Discover the world of telemedicine

M-health & Medical Apps

Case studies

Latest insights

Upcoming events

Relevant Downloads

What's on TwoBirds TV?

Australian regulators are shining a spotlight on #greenwashing and taking enforcement action against businesses promoting dubious #ESG claims. Click here to read more: https://t.co/fHitfE81hR https://t.co/2SPhonWnEW

twobirds | Mar 30

We are delighted to announce that Graeme Maguire has been reappointed as Chair, effective 1 April 2023. A huge congratulations to Graeme. Click here to read more: https://t.co/OgV03lmVSz https://t.co/yCoAy5PSWS

twobirds | Mar 29

In this recent article, we discuss the potential regulatory implications for crypto-asset service providers who intend to offer services related to these assets. Click here to read more: https://t.co/vAKSpy52Uw https://t.co/M965xgKL3S

twobirds | Mar 28

We are delighted to share the latest edition of Check-in - our quarterly newsletter helping you stay up to date with the latest news, trends and hot topics in the international Hotels, Hospitality & Leisure market. Click here to read more: https://t.co/BufyepeIYf https://t.co/hhuUNJVAji

twobirds | Mar 27

twobirds | Mar 23

Accolades

Chambers and Partners 2021 – Life Sciences: Europe-wide - Band 1 Asia-Pacific- Band 1 UK Life Sciences & Pharmaceutical Sector (International & Cross-Border) - Band 1

Chambers and Partners 2021 – Life Sciences

"They take a pragmatic and commercial approach, and are able to explain complex concepts in a simple and easy to understand format."

Chambers and Partners, Asia-Pacific 2021

"We chose Bird & Bird because they are internationally oriented. They come up with decisions that are favourable for the client and do not just prolong litigation."

Chambers and Partners, Global 2021

“[The team] provides geographical breadth and uniform excellence throughout. They are excellent and know the nuts and bolts of life sciences."

Chambers and Partners, UK 2022

Chambers & Partners UK 2022 – Life Sciences: Band 1

Chambers & Partners UK 2022

“Working with Bird & Bird was a pleasure. It was a real team effort and they worked well together to get the best result.”

Chambers Europe 2021

"They remain at the pinnacle of the profession as regards their life sciences work."

Legal 500, 2020

“This practice is unique because they have such great experience and knowledge in such a large amount of localities. They are great to work with because they have very talented attorneys in lots of countries and can really help out international companies and support their growth.”

Legal 500 2022

Legal 500 UK 2022 – Life Sciences and Healthcare: Tier 1

Legal 500 UK 2022

LMG Life Sciences Europe Awards 2021: European Regulatory Firm of the Year, European Venture Capital Firm of the Year, Patent Litigation Firm of the Year – Medical Devices

LMG Life Sciences Europe Awards 2021

LMG Life Sciences Awards EMEA 2022

Who's Who Legal 2020

Bird & Bird

News & Deals